Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in Helen of Troy Limited... (PR Newswire) +++ HELEN OF TROY Aktie -4,12%

MINDWALK Aktie

 >MINDWALK Aktienkurs 
1.06 EUR    -15.2%    (TradegateBSX)
Ask: 1.08 EUR / 4600 Stück
Bid: 1.06 EUR / 4800 Stück
Tagesumsatz: 4020 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MINDWALK Aktie über LYNX handeln
>MINDWALK Performance
1 Woche: +0,8%
1 Monat: -5,2%
3 Monate: +16,4%
6 Monate: -32,3%
1 Jahr: 0%
laufendes Jahr: -9,9%
>MINDWALK Aktie
Name:  MINDWALK HOLDINGS CORP.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA6026871054 / A41GYL
Symbol/ Ticker:  TQB0 (Frankfurt) / HYFT (NASDAQ)
Kürzel:  FRA:TQB0, ETR:TQB0, TQB0:GR, NASDAQ:HYFT
Index:  -
Profil:  MindWalk Holdings Corp. is a pioneering bio-native artificial intelligence company specializing in the acceleration of drug discovery and development. Established in 1983, the company integrates cutting-edge AI, multi-omics data, and laboratory resea..
>Volltext..
Marktkapitalisierung:  58.59 Mio. EUR
Unternehmenswert:  52.01 Mio. EUR
Umsatz:  11.56 Mio. EUR
EBITDA:  -6.21 Mio. EUR
Nettogewinn:  -7.73 Mio. EUR
Gewinn je Aktie:  -0.17 EUR
Schulden:  2.28 Mio. EUR
Liquide Mittel:  9.11 Mio. EUR
Operativer Cashflow:  -7.06 Mio. EUR
Bargeldquote:  2.8
Umsatzwachstum:  -33.86%
Gewinnwachstum:  76.84%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel -
Suchwörter:  MINDWALK
Letzte Datenerhebung:  23.07.26
>MINDWALK Kennzahlen
Aktien/ Unternehmen:
Aktien: 46.71 Mio. St.
Frei handelbar: 90.67%
Leerverk. Aktien: -
Rückkaufquote: -1%
Mitarbeiter: 102
Umsatz/Mitarb.: 0.15 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 211.99%
Bewertung:
KGV: -
KGV lG: -
KUV: 6.04
KBV: 6.1
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 59.7%
Gewinnmarge: -73.2%
Operative Marge: -66.1%
Managementeffizenz:
Gesamtkaprendite: -39.85%
Eigenkaprendite: -68.13%
>MINDWALK Peer Group
Gesundheit, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika
 
23.07.26 - 15:09
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers (PR Newswire)
 
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) USA News Group News Commentary NEW YORK, July 23, 2026 /PRNewswire/ -- For years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can talk about......
23.07.26 - 03:15
MindWalk Holdings Corp. (HYFT) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
 
MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -20.00% and -8.80%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?...
22.07.26 - 23:00
MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure (Business Wire)
 
Full-year revenue rose 46% to $15.6 million with gross margin expanding to 59%; net loss narrowed by more than half as MindWalk sharpened its focus on the BioIntelligence infrastructure powering AI drug discovery.AUSTIN, Texas--(BUSINESS WIRE)--$HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for the fiscal year ended April 30, 2026. All figures are in Canadian dollars unless otherwise noted. Fiscal 2026 was the year MindWalk completed its transition from building its technology to deploying it. Revenue grew 46% year over year, gross margin expanded, the net loss narrowed by more than half, and the Company divested a non-core business to concentrate on the BioIntelligence infrastructure that life sciences AI and agentic AI require. "We are not an AI company that discovered biology. We are a biology company that built AI on top of more than 40 years of biology heritage, and fiscal 2026 is the year the market began to se...
15.07.26 - 14:51
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 (PR Newswire)
 
Issued on behalf of MindWalk Holdings Corp. MindWalk Holdings Corp. (NASDAQ: HYFT) heads into its fourth-quarter and full-year results with fresh index inclusion, an expanded patent estate, and AI-designed programs aimed at two of medicine's biggest frontiers: GLP-1 metabolic health and......
13.07.26 - 15:06
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026 (Business Wire)
 
MindWalk to host an earnings conference call and webcastAUSTIN, Texas--(BUSINESS WIRE)--$HYFT #ai--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the fourth quarter and full fiscal year 2026 and host a conference call on Wednesday, July 22, 2026, at 5:00 p.m. Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session. Conference Call and Webcast Details Event Date and Time: Wednesday, July 22, 2026, at 5:00 p.m. Eastern Time The conference call will be webcast live and available for replay via a link provided in the Events section of the Company's Investor Relations pages at: https://ir.mindwalkai.com/events-and-presentations/default.aspx Participant Dial-Ins: USA / International Toll: +1 (646) 307-1963 USA Toll-Free: (800) 715-9871 Canada (Toronto): (647) 932-3411 Canada Toll-Free...
06.07.26 - 15:03
MindWalk Holdings added to Russell 3000E Index (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.07.26 - 14:57
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models (PR Newswire)
 
Issued on behalf of MindWalk Holdings Corp. MindWalk Holdings Corp. (NASDAQ: HYFT) filed a European patent application directed to the high-dimensional biological data architecture beneath its HYFT® Technology, ReefIQ™, and LensAI™, the model-agnostic context layer designed to let AI......
16.06.26 - 14:48
The Quiet Bottleneck in AI Drug Discovery Isn′t the Model -- It′s the Biology Underneath It (PR Newswire)
 
Issued on behalf of MindWalk Holdings Corp. Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that is where one Nasdaq-listed company has placed......
02.06.26 - 13:31
Präklinische Dengue-Daten von MindWalk stützen eine rechnergestützte HYFT®-Vorhersage: Auf das vorhergesagte Zielmolekül ausgelegte Immunogene erzeugten kreuzreaktive Antikörper gegen Antigene aller vier Dengue-Serotypen (IRW Press)
 
Präklinische Dengue-Daten von MindWalk stützen eine rechnergestützte HYFT®-Vorhersage: Auf das vorhergesagte Zielmolekül ausgelegte Immunogene erzeugten kreuzreaktive Antikörper gegen Antigene aller......
12.03.26 - 17:48
MindWalk (HYFT) Q3 2026 Earnings Call Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
12.03.26 - 13:42
MindWalk GAAP EPS of -$0.08 misses by $0.04, revenue of $4.16M beats by $0.82M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.03.26 - 13:36
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results (Business Wire)
 
Third Consecutive Quarter of Year-Over-Year Revenue Growth | First Annual Enterprise LensAI™ Platform Contract | Launch of B cell Llama™ Nanobody Discovery PlatformAUSTIN, Texas--(BUSINESS WIRE)--$HYFT #ai--MindWalk Holdings Corp. (Nasdaq: HYFT), a Bio-Native AI company focused on biologics discovery and AI-driven drug development, today reported financial results for the third quarter of fiscal year 2026, ended January 31, 2026. MindWalk will host its Q3 Fiscal 2026 Earnings Call today at 10:30 AM Eastern Time. Revenue for Q3 was $4.2 million, a 52 percent increase from $2.7 million in Q3 fiscal 2025, marking MindWalk's third consecutive quarter of year-over-year revenue growth. US revenue doubled year over year to $2.6 million. The Company's largest enterprise AI client signed a one-year LensAI platform contract, the first contracted, recurring platform revenue agreement in the Company's history, shifting a part of MindWalk's revenue from project-based to contracted and recurring. “This quarte...
11.03.26 - 17:36
MindWalk Q3 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.03.26 - 22:06
MindWalk stellt B Cell Llama(TM) vor — eine Nanobody-Discovery-Plattform für das bispezifische und zelltherapeutische Zeitalter (IRW Press)
 
Peer-reviewte Studie in ACS Biomacromolecules belegt modulare VHH-Potenz, variantenunabhängige therapeutische Aktivität und einen erstmals beschriebenen Immun-Priming-Mechanismus; MindWalk hält das......
02.03.26 - 14:33
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 (Business Wire)
 
The Company to host an earnings conference call via webcastAUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced that it will report financial results for the third quarter of fiscal year 2026 and host a conference call on Thursday, March 12, 2026, at 10:30 AM Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session. Conference Call and Webcast Details The live webcast will take place on Thursday, March 12, 2026, at 10:30AM ET. The conference call will be webcast live and available for replay via a link provided in the Events section of the Company's IR pages at: https://ir.mindwalkai.com/events-and-presentations/default.aspx * Webcast Details * Event Title: MindWalk Holdings Corp. – Third Quarter Fiscal Year 2026 Financial Results Event Date: March 12, 2026, ...
27.01.26 - 06:06
MindWalk setzt HYFT®-Technologie zur Erkennung funktionaler Adjazenz mit Bezug zu Portfoliorisiken bei KI-designten Therapeutika ein (IRW Press)
 
AUSTIN, Texas / IRW-Press / MindWalk Holdings Corp. (NASDAQ:HYFT) (MindWalk oder das Unternehmen), ein Bio-Native-AI-Unternehmen für therapeutische Forschung und Technologie, gab heute die Anwendung......
14.01.26 - 14:06
MindWalk validiert die Präzision seiner Plattform mit einer bahnbrechenden Entdeckung zur pathogenen Form des Schlüsselproteins TDP-43 bei neurodegenerativen Erkrankungen (IRW Press)
 
14. Januar 2026 VICTORIA, British Columbia / IRW-Press / MindWalk Holdings Corp. (MindWalk oder das Unternehmen) (Nasdaq: HYFT) hat heute die Entdeckung und Validierung von monoklonalen Antikörpern......
10.01.26 - 02:12
MindWalk treibt universelles Influenza-Programm mit bahnbrechender funktioneller Erkenntnis voran (IRW Press)
 
Validierung über Influenza A und Influenza B hinweg, einschließlich der H3N2-Subklade K sowie zoonotischer Influenza-A-Subtypen H5, H7 und H9 Austin, Texas 9. Januar 2026 / IRW-Press / MindWalk......
15.12.25 - 18:06
Earnings Call: MindWalk meldet 54 % Umsatzwachstum für Q2 2025 (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
15.12.25 - 17:30
MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
 
MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -400.00% and -25.68%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Mensch ist reich genug, um sich die eigene Vergangenheit zurückkaufen zu können. - Oscar Wilde
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!